Print this page    •   Back to Web version of article

New 800-mg Prezista

By Enid Vázquez

January/February 2013

Photo courtesy of Janssen Pharmaceuticals.

Photo courtesy of Janssen Pharmaceuticals.

The long-awaited 800-mg Prezista tablet has been approved by the FDA. Previously, people on Prezista took two 400-mg tablets once a day (with Norvir). Prezista must still be taken with Norvir and food, but now only one pill once a day. Kudos to Janssen Pharmaceuticals for reducing pill burden for Prezista patients.

Janssen plans to phase out the 400-mg pills. Still in the works is a co-formulated pill with a drug level booster built right in, combining Prezista with the PK (pharmacokinetic) enhancer cobicistat. This would eliminate the need for taking Norvir. Cobicistat by itself is not yet on the market, but is part of the recently FDA approved single tablet regimen Stribild.

The new tablet will be covered by the Janssen Patient Savings Program and the Johnson & Johnson Patient Assistance Foundation.


Got a comment on this article? Write to us at publications@tpan.com.




This article was provided by Positively Aware. It is a part of the publication Positively Aware. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/70282/new-800-mg-prezista.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.